704 related articles for article (PubMed ID: 23870911)
1. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone.
Dong X; Xu W; Sikes RA; Wu C
Food Chem; 2013 Dec; 141(3):1923-33. PubMed ID: 23870911
[TBL] [Abstract][Full Text] [Related]
2. Apoptotic effects of cooked and in vitro digested soy on human prostate cancer cells.
Dong X; Xu W; Sikes RA; Wu C
Food Chem; 2012 Dec; 135(3):1643-52. PubMed ID: 22953905
[TBL] [Abstract][Full Text] [Related]
3. Soy isoflavones augment the effect of TRAIL-mediated apoptotic death in prostate cancer cells.
Szliszka E; Krol W
Oncol Rep; 2011 Sep; 26(3):533-41. PubMed ID: 21637922
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells.
Hsu A; Bray TM; Helferich WG; Doerge DR; Ho E
Exp Biol Med (Maywood); 2010 Jan; 235(1):90-7. PubMed ID: 20404023
[TBL] [Abstract][Full Text] [Related]
5. Soy extract has different effects compared with the isolated isoflavones on the proteome of homocysteine-stressed endothelial cells.
Fuchs D; Dirscherl B; Schroot JH; Daniel H; Wenzel U
Mol Nutr Food Res; 2006 Jan; 50(1):58-69. PubMed ID: 16502433
[TBL] [Abstract][Full Text] [Related]
6. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro.
Hedlund TE; Johannes WU; Miller GJ
Prostate; 2003 Jan; 54(1):68-78. PubMed ID: 12481257
[TBL] [Abstract][Full Text] [Related]
7. Daidzein effect on hormone refractory prostate cancer in vitro and in vivo compared to genistein and soy extract: potentiation of radiotherapy.
Singh-Gupta V; Zhang H; Yunker CK; Ahmad Z; Zwier D; Sarkar FH; Hillman GG
Pharm Res; 2010 Jun; 27(6):1115-27. PubMed ID: 20309614
[TBL] [Abstract][Full Text] [Related]
8. Soy isoflavones in the treatment of prostate cancer.
Hussain M; Banerjee M; Sarkar FH; Djuric Z; Pollak MN; Doerge D; Fontana J; Chinni S; Davis J; Forman J; Wood DP; Kucuk O
Nutr Cancer; 2003; 47(2):111-7. PubMed ID: 15087261
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferation effect and mechanism of prostate cancer cell lines as affected by isoflavones from soybean cake.
Wang BF; Wang JS; Lu JF; Kao TH; Chen BH
J Agric Food Chem; 2009 Mar; 57(6):2221-32. PubMed ID: 19292464
[TBL] [Abstract][Full Text] [Related]
10. Multiple mechanisms of soy isoflavones against oxidative stress-induced endothelium injury.
Xu SZ; Zhong W; Ghavideldarestani M; Saurabh R; Lindow SW; Atkin SL
Free Radic Biol Med; 2009 Jul; 47(2):167-75. PubMed ID: 19393315
[TBL] [Abstract][Full Text] [Related]
11. Soy isoflavones suppress invasiveness of breast cancer cells by the inhibition of NF-kappaB/AP-1-dependent and -independent pathways.
Valachovicova T; Slivova V; Bergman H; Shuherk J; Sliva D
Int J Oncol; 2004 Nov; 25(5):1389-95. PubMed ID: 15492830
[TBL] [Abstract][Full Text] [Related]
12. Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model.
Raffoul JJ; Banerjee S; Che M; Knoll ZE; Doerge DR; Abrams J; Kucuk O; Sarkar FH; Hillman GG
Int J Cancer; 2007 Jun; 120(11):2491-8. PubMed ID: 17304503
[TBL] [Abstract][Full Text] [Related]
13. Red clover and soy isoflavones--an in vitro safety assessment.
Reiter E; Gerster P; Jungbauer A
Gynecol Endocrinol; 2011 Dec; 27(12):1037-42. PubMed ID: 21801124
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia.
Fischer L; Mahoney C; Jeffcoat AR; Koch MA; Thomas BE; Valentine JL; Stinchcombe T; Boan J; Crowell JA; Zeisel SH
Nutr Cancer; 2004; 48(2):160-70. PubMed ID: 15231450
[TBL] [Abstract][Full Text] [Related]
15. Reduced isoflavone metabolites formed by the human gut microflora suppress growth but do not affect DNA integrity of human prostate cancer cells.
Raschke M; Wähälä K; Pool-Zobel BL
Br J Nutr; 2006 Sep; 96(3):426-34. PubMed ID: 16925846
[TBL] [Abstract][Full Text] [Related]
16. Membrane fluidity, invasiveness and dynamic phenotype of metastatic prostate cancer cells after treatment with soy isoflavones.
Ajdžanović V; Mojić M; Maksimović-Ivanić D; Bulatović M; Mijatović S; Milošević V; Spasojević I
J Membr Biol; 2013 Apr; 246(4):307-14. PubMed ID: 23417033
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
[TBL] [Abstract][Full Text] [Related]
18. Molecular signatures of soy-derived phytochemicals in androgen-responsive prostate cancer cells: a comparison study using DNA microarray.
Takahashi Y; Lavigne JA; Hursting SD; Chandramouli GV; Perkins SN; Kim YS; Wang TT
Mol Carcinog; 2006 Dec; 45(12):943-56. PubMed ID: 16865672
[TBL] [Abstract][Full Text] [Related]
19. Isoflavones inhibit proliferation of ovarian cancer cells in vitro via an estrogen receptor-dependent pathway.
Chen X; Anderson JJ
Nutr Cancer; 2001; 41(1-2):165-71. PubMed ID: 12094620
[TBL] [Abstract][Full Text] [Related]
20. Retinoid-induced epidermal hyperplasia in human skin organ culture: inhibition with soy extract and soy isoflavones.
Varani J; Kelley EA; Perone P; Lateef H
Exp Mol Pathol; 2004 Dec; 77(3):176-83. PubMed ID: 15507233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]